Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/26/2014 | EP2709625A1 Enantiomers of fluconazole analogues containing thieno-[2,3-d] pyrimidin-4(3h)-one moiety as antifungal agents |
03/26/2014 | EP2709624A1 N-methyl tetrahydroquinoline m1 receptor positive allosteric modulators |
03/26/2014 | EP2709623A2 Medicaments and methods for treating cancer |
03/26/2014 | EP2709622A2 Kinase modulation and indications therefor |
03/26/2014 | EP2709621A1 N-linked quinolineamide m1 receptor positive allosteric modulators |
03/26/2014 | EP2709620A1 Use of sigma ligands in diabetes type-2 associated pain |
03/26/2014 | EP2709619A2 Compounds for use in treatment of mucositis |
03/26/2014 | EP2709618A1 Methods for the treatment and diagnostic of pulmonary arterial hypertension |
03/26/2014 | EP2709617A1 The use of secnidazole in treating dental infections |
03/26/2014 | EP2709616A1 A stable micronised monoclinic form of asenapine maleate and its synthesis |
03/26/2014 | EP2709615A1 Monoclinic crystalline form of asenapine maleate with a specific particle size distribution |
03/26/2014 | EP2709614A1 Pharmaceutical compositions and methods for treating cancer |
03/26/2014 | EP2709613A2 Methods for treating hcv |
03/26/2014 | EP2709612A2 Compositions and methods for treating and preventing cancer by targeting and inhibiting cancer stem cells |
03/26/2014 | EP2709611A2 Medical food for cognitive decline |
03/26/2014 | EP2709610A1 High concentration olopatadine ophthalmic composition |
03/26/2014 | EP2709609A1 Heterocyclic compounds |
03/26/2014 | EP2709608A1 Method of treating postural reflex abnormality caused by parkinson's disease |
03/26/2014 | EP2709607A1 A water soluble composition comprising curcumin having enhanced bioavailability and process thereof |
03/26/2014 | EP2709606A1 Compositions containing resveratrol and essential oil of cloves for the treatment of itching |
03/26/2014 | EP2709605A1 An antioxidant composition |
03/26/2014 | EP2709604A1 Cannabinoids for use in the treatment of neuropathic pain |
03/26/2014 | EP2709603A1 Modified biotin-binding protein, fusion proteins thereof and applications |
03/26/2014 | EP2709602A1 Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure |
03/26/2014 | EP2709600A1 Pharmaceutical composition comprising fexofenadine |
03/26/2014 | EP2709599A1 Pharmaceutical composition comprising drotaverine |
03/26/2014 | EP2709598A1 Pharmaceutical composition comprising ketoprofen |
03/26/2014 | EP2709597A2 Drug delivery system |
03/26/2014 | EP2709596A1 Effervescent formulations comprising dexketoprofen |
03/26/2014 | EP2709593A2 Multi-particulate pharmaceutical composition |
03/26/2014 | EP2709592A1 Pharmaceutical composition of rosuvastatin calcium |
03/26/2014 | EP2709588A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration |
03/26/2014 | EP2709587A2 Water-soluble formulations comprising dexketoprofen |
03/26/2014 | EP2709460A1 Composition comprising vitamin k2 |
03/26/2014 | EP2709455A2 Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives |
03/26/2014 | EP2709453A1 Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections |
03/26/2014 | EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators |
03/26/2014 | EP2709450A1 Identification of compounds that disperse tdp-43 inclusions |
03/26/2014 | EP2709447A1 Compositions, methods & systems for respiratory delivery of two or more active agents |
03/26/2014 | CN203494017U Targeted information gas preparing device |
03/26/2014 | CN103687946A Peptide for inducing regeneration of tissue and use thereof |
03/26/2014 | CN103687866A Purine monophosphate prodrugs for treatment of viral infections |
03/26/2014 | CN103687864A Bifunctional phosphonate chelating agents |
03/26/2014 | CN103687860A Heterocyclic amide derivatives as P2X7 receptor antagonists |
03/26/2014 | CN103687858A Amino-substituted imidazopyridazines as MKNK1 kinase inhibitors |
03/26/2014 | CN103687856A A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes |
03/26/2014 | CN103687855A Imidazole derivatives |
03/26/2014 | CN103687853A Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
03/26/2014 | CN103687852A 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors |
03/26/2014 | CN103687849A (--)- huperzine a processes and related compositions and methods of treatment |
03/26/2014 | CN103687843A Quinone based nitric oxide donating compounds |
03/26/2014 | CN103687603A Method for alleviating fear memory |
03/26/2014 | CN103687601A Method of treatment or prophylaxis of bacterial vaginosis |
03/26/2014 | CN103687600A A novel process for preparation of polysaccharides |
03/26/2014 | CN103687598A Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor |
03/26/2014 | CN103687597A PARP inhibitors for the treatment of CIPN |
03/26/2014 | CN103687596A Solid pharmaceutical composition |
03/26/2014 | CN103687595A Novel compounds as diacylglycerol acyltransferase inhibitors |
03/26/2014 | CN103687594A Ophthalmic treatments |
03/26/2014 | CN103687593A Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure |
03/26/2014 | CN103687592A Pharmaceutical composition comprising fexofenadine |
03/26/2014 | CN103687591A Capsule formulation comprising montelukast and levocetirizine |
03/26/2014 | CN103687587A Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
03/26/2014 | CN103687581A Novel haemostatic composition |
03/26/2014 | CN103687500A Metabolic imprinting effects of specifically designed lipid component |
03/26/2014 | CN103687495A Composition comprising vitamin k2 |
03/26/2014 | CN103687489A Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives |
03/26/2014 | CN103675152A Nitroglycerin micro-emulsion spray content assaying method and application |
03/26/2014 | CN103667420A Method for screening virus activity-adjusting compound by taking MAPK family proteins as targets |
03/26/2014 | CN103667410A Fuscoporia obliqua fermentation product, preparation method and application thereof |
03/26/2014 | CN103665180A Application of Morindae officinalis oligosaccharide 6 glycan in preparation of myocardial ischemia and reperfusion injury resistance medicines |
03/26/2014 | CN103665176A Fructan extract, and preparation method and application thereof |
03/26/2014 | CN103665175A Fructan extract, and preparation method and application thereof |
03/26/2014 | CN103665091A Ilex dipyrena Lindl.et Paxt. saponin compound, and preparation method and application thereof |
03/26/2014 | CN103665090A Ilex dipyrena Lindl.et Paxt. saponin compound, and preparation method and application thereof |
03/26/2014 | CN103665089A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103665088A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103665087A Terpenoid and application thereof in medicine |
03/26/2014 | CN103665082A Hemsleya cucurbitane tetracyclic triterpenoid compound, pharmaceutical compositions containing same and application of compound and pharmaceutical composition |
03/26/2014 | CN103665080A Triterpenoid compounds and application thereof in diabetes treatment drugs |
03/26/2014 | CN103665071A Gopalamicin derivatives and application of same in inhibition of infection by drug-resistant bacteria and drug-resistant mycobacterium tuberculosis |
03/26/2014 | CN103665069A Aminoglycoside compound and extraction separation method thereof |
03/26/2014 | CN103665059A Nature crocin extraction separation method and preparation for crocin blood fat reduction drug |
03/26/2014 | CN103665046A Ruthenium complex as well as preparation method and application thereof |
03/26/2014 | CN103665043A Tenofovir prodrug and medical application thereof |
03/26/2014 | CN103665042A Optically active 2-hydroxyltetrahydrothienopyridine derivative as well as preparation method and use thereof |
03/26/2014 | CN103665027A Alizarin vanadium complex, and preparation method and application thereof |
03/26/2014 | CN103665004A Compounds for treating narrow chamber angle and application thereof |
03/26/2014 | CN103665000A Preparation method and another use of cephalosporin |
03/26/2014 | CN103664997A Antitumor compound extracted from gamboge and preparation method and application thereof |
03/26/2014 | CN103664996A Indole derivative and preparation method thereof |
03/26/2014 | CN103664993A Compounds for treating ischemic brain injury and application thereof |
03/26/2014 | CN103664992A Compounds for treating ischemic brain injury and application thereof |
03/26/2014 | CN103664991A Thiophene [2, 3-d] pyrimidine derivative as well as preparation method and use thereof |
03/26/2014 | CN103664986A Antineoplastic compound extracted from gamboges, preparation method and application of antineoplastic compound |
03/26/2014 | CN103664984A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103664983A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103664979A Antineoplastic compound extracted from gamboge, and preparation method and application thereof |
03/26/2014 | CN103664974A Aryl [a] indole [2,3-g] quinolizine compound as well as preparation method, pharmaceutical composition and application thereof |
03/26/2014 | CN103664973A Spiro-oxindole compounds and their use as therapeutic agents |